Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | FKBP5 | Q13451 | 1/20 | 0.37 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.37 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.37 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.37 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.37 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.37 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.37 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.37 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 3/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | PARP1 | P09874 | 4/20 | 0.34 |
| ▸ | BCHE | P06276 | 1/20 | 0.33 |
| ▸ | PHLPP2 | Q6ZVD8 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Caprolactam SCHEMBL6408803 | 0.95 | FKBP5 (0.42) | OR51E2THRBFKBP5CRBNCHRM2 | |
| Sulfuric Acid Dimethyl Ester SCHEMBL27866743 | 0.92 | OR51E2 (0.35) | OR51E2THRBFKBP5CRBNCHRM2 | |
| 2-Pyrrolidone SCHEMBL27469715 | 0.86 | OR51E2 (0.40) | OR51E2THRBFKBP5CRBNCHRM2 | |
| 2-Pyrrolidone SCHEMBL28304483 | 0.84 | OR51E2 (0.46) | OR51E2THRBFKBP5CRBNTSHR | |
| 2-Pyrrolidone SCHEMBL17241782 | 0.84 | OR51E2 (0.46) | OR51E2THRBFKBP5CRBNTSHR | |
| 2-Pyrrolidone SCHEMBL8133376 | 0.82 | OR51E2 (0.47) | OR51E2THRBFKBP5CRBNTSHR | |
| 2-Pyrrolidone SCHEMBL27468084 | 0.82 | OR51E2 (0.41) | OR51E2THRBFKBP5CRBNCHRM2 | |
| 2-Pyrrolidone SCHEMBL8168482 | 0.82 | TSHR (0.55) | OR51E2THRBFKBP5CRBNL3MBTL1 | |
| Caprolactam SCHEMBL5610881 | 0.82 | FKBP5 (0.40) | OR51E2THRBFKBP5CRBNCHRM2 | |
| 2-Pyrrolidone SCHEMBL28270057 | 0.80 | OR51E2 (0.44) | OR51E2THRBFKBP5CRBNTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 404 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4384310-A1 | DEGRADABLE DELIVERY PARTICLES BASED FROM AMINE CONTAINING NATURAL MATERIALS | Encapsys, LLC (US) | 2024-06-19 | — | — | EP | claimed |
| EP-3596192-B1 | BENEFIT AGENT CONTAINING DELIVERY PARTICLE SLURRIES | PROCTER & GAMBLE (US) | 2024-05-15 | — | — | EP | claimed |
| US-20240147990-A1 | Delivery Particles Based On Amine-Thiol-Ene Conjugates and Derivatives | ENCAPSYS, LLC (US) | 2024-05-09 | — | — | US | claimed |
| WO-2024086501-A1 | DELIVERY PARTICLES BASED ON AMINE-THIOL-ENE CONJUGATES AND DERIVATIVES | ENCAPSYS, LLC (US) | 2024-04-25 | — | — | WO | claimed |
| CN-117813153-A | Degradable delivery particles based on amine-containing natural materials | 恩盖普有限公司 | 2024-04-02 | — | — | CN | claimed |
| US-20240002745-A1 | BIODEGRADABLE DELIVERY PARTICLES | ENCAPSYS, LLC (US) | 2024-01-04 | — | — | US | claimed |
| US-20240000073-A1 | BIODEGRADABLE DELIVERY PARTICLES | ENCAPSYS, LLC (US) | 2024-01-04 | — | — | US | claimed |
| US-20230313084-A1 | BENEFIT AGENT CONTAINING DELIVERY PARTICLE | PROCTER & GAMBLE (US) | 2023-10-05 | — | — | US | claimed |
| EP-4247896-A1 | BIODEGRADABLE DELIVERY PARTICLES | Encapsys, LLC (US) | 2023-09-27 | — | — | EP | claimed |
| EP-4247162-A1 | BIODEGRADABLE DELIVERY PARTICLES | Encapsys, LLC (US) | 2023-09-27 | — | — | EP | claimed |
| US-8765659-B2 | Cationic polymer stabilized microcapsule composition | THE PROCTER & GAMBLE COMPANY (US) | 2014-07-01 | — | — | US | claimed |
| EP-2674477-A1 | Cationic polymer stabilized microcapsule composition | The Procter and Gamble Company (US) | 2013-12-18 | — | — | EP | claimed |
| US-20110245141-A1 | CATIONIC POLYMER STABILIZED MICROCAPSULE COMPOSITION | THE PROCTER & GAMBLE COMPANY | 2011-10-06 | — | — | US | claimed |
| US-7799752-B2 | Compositions comprising encapsulated material | QUEST INTERNATIONAL SERVICES B.V. (NL) | 2010-09-21 | — | — | US | claimed |
| EP-2046935-A2 | CATIONIC POLYMER STABILIZED MICROCAPSULE COMPOSITION | Colgate-Palmolive Company (US) | 2009-04-15 | — | — | EP | claimed |
| CN-101212957-A | Pharmaceutical sustained-release composition and preparation method thereof | PANACEA BIOTEC LTD (IN) | 2008-07-02 | — | — | CN | claimed |
| WO-2008005693-A2 | CATIONIC POLYMER STABILIZED MICROCAPSULE COMPOSITION | COLGATE-PALMOLIVE COMPANY (US) | 2008-01-10 | — | — | WO | claimed |
| CN-1518590-A | Process for preparation of water-soluble particles of saldimine-type manganese complexes | �������⻯ѧƷ�ع�����˾ | 2004-08-04 | — | — | CN | claimed |
| EP-1354025-A1 | PROCESS FOR THE PREPARATION OF WATER-SOLUBLE GRANULES OR PARTICLES OF SALDIMINE-TYPE MANGANESE COMPLEXES | Ciba SC Holding AG (CH) | 2003-10-22 | — | — | EP | claimed |
| WO-2002059245-A1 | PROCESS FOR THE PREPARATION OF WATER-SOLUBLE GRANULES OR PARTICLES OF SALDIMINE-TYPE MANGANESE COMPLEXES | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2002-08-01 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240000073-A1 | BIODEGRADABLE DELIVERY PARTICLES | VEGFA, FIBP, HDLBP | OR51E2 3842/4885THRB 1561/4885FKBP5 1835/4885 |
| US-20240147990-A1 | Delivery Particles Based On Amine-Thiol-Ene Conjugates and Derivatives | ACR, MMAB, UBE3C | OR51E2 20/4885THRB 1780/4885FKBP5 1643/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.